Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Research Coverage on Small and Micro-Cap Companies

Equity Bottom-Up

<ul><li> Volition's Nu.Q Vet Canine Cancer Screening Test are being launched in the U.S. and Europe by Antech on its Element I+ diagnostic point-of-sale platform and in Japan by Fujifilm Vet Systems.</li><li>Sales are expected to accelerate during 2H 2024.</li><li> Nu.Q Discover has pipeline of opportunities valued at over $1 million.</li></ul>

 Volition's Nu.Q Vet Canine Cancer Screening Test are being launched in the U.S. and Europe by Antech on its Element I+ diagnostic point-of-sale platform and in Japan by Fujifilm Vet Systems.Sales are expected to accelerate during 2H 2024. Nu.Q Discover has pipeline of opportunities valued at over $1 million.

VNRX: Cost cutting being implemented in a plan to be cash flow neutral in 2025. Revenues from Nu.Q Vet Test Expected to Accelerate During 2H 2024

VolitionRX

VNRX: Cost cutting being implemented in a plan to be cash flow neutral in 2025. Revenues from Nu.Q Vet Test Expected to Accelerate During 2H 2024